Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for Patients Undergoing Abdominal Aortic Aneurysm Surgery
Multi-centre, Pilot Study Evaluating the Feasibility, Acceptability, and Short-term Outcomes of a Tailored, Virtual, Home-based, Multicomponent Prehabilitation Programme in Patients Undergoing Abdominal Aortic Aneurysms (AAA) Repair.
1 other identifier
interventional
40
1 country
1
Brief Summary
Design A multi-centre pilot study investigating the acceptability and adherence of a prehabilitation on patients requiring abdominal aortic aneurysm repair. Setting 3 NHS Hospital Vascular Surgery Clinics in the UK.
- Imperial College Healthcare NHS Trust
- Cambridge University Hospitals NHS Trust
- Mid and South Essex NHS Trust Patient Population Patients referred to secondary/tertiary vascular clinic for the repair of asymptomatic infrarenal Aneurysm Intervention: Baseline (conducted face-to-face): After providing written informed consent, participants will be provided with information about the prehabilitation programme. The following data will also be collected: baseline demographic characteristics (including age, sex and ethnicity), body mass index (BMI), medical history (including time since diagnosis), current medication, aneurysm diameter, health-related quality of life (EQ-5D-5L and EQ-VAS), smoking status and psychological wellbeing (using the Hospital Anxiety and Depression Scale; HADS) and Frailty assessments( QMortality Index, Electronic Frailty Index, Rockall score). Participants will also complete a 6-minute walking test(6MWT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedOctober 30, 2023
October 1, 2023
2.1 years
March 4, 2021
October 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility of screening and recruitment
The number of participants referred at each site will be captured The number of participants eligible for screening at each site will be captured The number of participants enrolled at each site will be captured Reasons for non-participation will be captured
18 months
Feasibility of measurement tools:
Time taken to complete the questionnaires at each time-point The ratio of missing data from questionnaires Follow-up response rates
18 months
Adherence
Number of sessions attended The proportion of participants who complete' the 6-week programme
at least 6 weeks ( Duration of the programme)
Acceptability of the prehabilitation programme (Patient satisfaction)
Patient satisfaction will be measured using questionnaires Reasons for drop-out will be captured.
18 months
Secondary Outcomes (10)
In-Hospital Complication Rate
Immediately after the surgery
30-day(After surgery) Composite Outcome
30 days
Length of stay and readmission rates (30 days post-surgery)
30 days
Change in 6-minute walk test (6-MWT) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
6 weeks, 3 months
Change in health-related quality of life scores (using the EuroQol five-dimensional questionnaire [EQ-5D] and visual analogue scale [EQ-VAS]) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
6 weeks, 3 months
- +5 more secondary outcomes
Study Arms (1)
Prehabilitation group
EXPERIMENTALThis arm will be subject to at least 6 weeks of a tailored prehabilitation programme
Interventions
Eligibility Criteria
You may qualify if:
- Adults (aged 55 years and over) who have been diagnosed with an AAA and are scheduled to undergo EVAR or open surgery (with a wait time of at least 6-weeks for surgery).
- Patients with an AAA with a diameter of 5.5cm to 7cm
- Able to write, understand and communicate in English
- Willing and able to participate in a virtual prehabilitation programme
You may not qualify if:
- Thoraco-Abdominal Aneurysms
- Connective tissue Vascular Disorder
- Symptomatic aneurysms
- Previous Aortic intervention
- Absolute contraindication to exercise
- Inability or unwillingness to participate in the trial
- Infrarenal AAA diameter exceeding 7.0cm
- Emergency AAA repair
- BMI below 20 kg/m2 or above 45 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial College London
London, W68RF, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alun Davies
Imperial College NHS Trust
- PRINCIPAL INVESTIGATOR
Tristan Lane
Cambridge University Hospitals NHS Trust
- PRINCIPAL INVESTIGATOR
Ankur Thapar
Mid and South Essex NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 11, 2021
Study Start
September 1, 2021
Primary Completion
October 1, 2023
Study Completion
October 1, 2023
Last Updated
October 30, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share